Technology Innovations and Growth Opportunities in Breast Cancer Diagnosis
Published on: 03-Dec-2024 | SKU: HC_2024_1169

Need more details?
$4,950.00
DownloadLink
Need more details?

Mammography and tissue biopsy have been the gold standard to detect breast cancer. Repeated mammography to assess the treatment response or disease prognosis results in frequent radiation exposure. In women with dense breasts In women with dense breasts, which have more fibrous and glandular tissues, mammograms show a white image similar to cancerous tissues. This similarity can lead to false negatives and delay the diagnosis. To overcome these problems, companies are looking to develop noninvasive, cost-effective, and specific tools for breast cancer diagnosis, leveraging nonionizing radiation and ultrasound technologies. This report provides a comprehensive analysis of various nonionizing radiation-based and acoustic diagnostic methods for diagnosing breast cancer. It covers technological innovations in breast cancer diagnostics and offers insights into patent trends, funding trends, cost-benefit analyses, and in-depth value chain analyses. It explores future growth opportunities and the impact of emerging technologies on adoption potential, patient comfort, and other crucial parameters. The report delves into public and private funding activities and research publication trends, emphasizing the importance of alternative optical, acoustic, and thermal methods in increasing diagnostic efficiency and aiding early breast cancer diagnosis.

This report explores technology breakthroughs in non-ionizing radiation and ultrasound technologies that enhance patient safety and diagnostic precision. Unlike conventional mammograms, which use ionizing radiation, techniques like thermography, optical imaging, microwave imaging and ultrasound technologies provide radiation-free alternatives to breast cancer diagnosis. AI algorithms enhance detection by identifying subtle patterns in tissue and vascular changes, especially in patients with denser breast tissues. Connectivity features enhance data sharing and integration into electronic health records, easing telehealth applications. While the devices are currently used as adjunct to mammography, hybrid diagnostic modalities integrating acoustic and non-ionizing radiation could potentially provide more diagnostic confidence and in future, could replace mammograms. Investing in these innovations can position the stakeholders at the forefront of the rapidly evolving breast cancer diagnostic devices market.

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Breast Cancer Diagnosis Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Scope of Analysis

Limitations of Traditional Mammographic and Biopsy Methods

Impact of Emerging Technologies on Breast Cancer Diagnosis

Segmentation

Comparison of Conventional Radiation-based Technologies and Emerging Acoustic and Nonionizing Radiation-based Technologies

Growth Drivers

Growth Restraints

Alternative Technologies to Mammography: Acoustic and Nonionizing Radiation-based Technologies in Breast Cancer Diagnosis

A Glimpse of Nonionizing Radiation Technologies for Breast Cancer Diagnosis

Insights into Breast Cancer Diagnosis Research: Trends in Publications on Alternative Technologies for Mammography (2020–2024)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Key Players Involved in Innovative Devices Using Nonionizing Radiation and Acoustic Technologies to Transform Breast Cancer Diagnosis (continued)

Case Study 1: Niramai Health Analytix, India

Case Study 2: Nextwear Technologies, Nigeria

Technology and Stakeholders Analysis: Breast Cancer Diagnostics Using Nonionizing Radiation and Acoustic Technologies, Global, 2024–2028

Impact Analysis of Major Nonionizing Radiation Technologies and Acoustic Technologies on Breast Cancer Diagnosis

Development Status of Nonionizing Radiation and Acoustic Technologies for Breast Cancer Diagnosis, Global, 2024–2028

Insights on the Analysis, Impact, and Development of Nonionizing Radiation and Acoustic Technologies for Breast Cancer Diagnosis

Trends in Breast Cancer Diagnostics Using Nonionizing Radiation and Acoustic Technologies, Global, 2024–2028

Partnership Analysis for Breast Cancer Diagnostics Technologies, Global, 2021–2024

Public and Private Funding for Breast Cancer Diagnostics Technologies, Global, 2021–2024

Patent Analysis for Breast Cancer Diagnostics Technologies, Global, 2021–2024

Nonionizing Radiation and Acoustic Technologies in Breast Cancer Diagnosis: Value Chain Snapshot

Analyst Insights: Value Chain Analysis for Nonionizing Radiation and Acoustic Technologies in Breast Cancer Diagnosis

Key Stakeholders in the Breast Cancer Diagnosis Value Chain: From R&D to End-user Adoption

Cost Analysis of Nonionizing Radiation and Ultrasound Modalities vs Conventional Mammogram

Cost Analysis of Nonionizing Radiation (Thermal Imaging) and Ultrasound Modalities vs Conventional Mammogram and MRI

Future Roadmap for Breast Cancer Diagnostics Technologies, 2024–2028

Growth Opportunity 1: AI-integrated Breast Cancer Diagnostics

Growth Opportunity 1: AI-integrated Breast Cancer Diagnostics (continued)

Growth Opportunity 2: Point-of-care (POC) and Wearable Devices for Breast Cancer Diagnosis

Growth Opportunity 2: Point-of-care (POC) and Wearable Devices for Breast Cancer Diagnosis (continued)

Growth Opportunity 3: Multimodal Diagnostic Systems to Detect Breast Cancer

Growth Opportunity 3: Multimodal Diagnostic Systems to Detect Breast Cancer (continued)

TRL: Explanation

Benefits and Impacts of Growth Opportunities

Next Steps

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Mammography and tissue biopsy have been the gold standard to detect breast cancer. Repeated mammography to assess the treatment response or disease prognosis results in frequent radiation exposure. In women with dense breasts In women with dense breasts, which have more fibrous and glandular tissues, mammograms show a white image similar to cancerous tissues. This similarity can lead to false negatives and delay the diagnosis. To overcome these problems, companies are looking to develop noninvasive, cost-effective, and specific tools for breast cancer diagnosis, leveraging nonionizing radiation and ultrasound technologies. This report provides a comprehensive analysis of various nonionizing radiation-based and acoustic diagnostic methods for diagnosing breast cancer. It covers technological innovations in breast cancer diagnostics and offers insights into patent trends, funding trends, cost-benefit analyses, and in-depth value chain analyses. It explores future growth opportunities and the impact of emerging technologies on adoption potential, patient comfort, and other crucial parameters. The report delves into public and private funding activities and research publication trends, emphasizing the importance of alternative optical, acoustic, and thermal methods in increasing diagnostic efficiency and aiding early breast cancer diagnosis.--BEGIN PROMO--

This report explores technology breakthroughs in non-ionizing radiation and ultrasound technologies that enhance patient safety and diagnostic precision. Unlike conventional mammograms, which use ionizing radiation, techniques like thermography, optical imaging, microwave imaging and ultrasound technologies provide radiation-free alternatives to breast cancer diagnosis. AI algorithms enhance detection by identifying subtle patterns in tissue and vascular changes, especially in patients with denser breast tissues. Connectivity features enhance data sharing and integration into electronic health records, easing telehealth applications. While the devices are currently used as adjunct to mammography, hybrid diagnostic modalities integrating acoustic and non-ionizing radiation could potentially provide more diagnostic confidence and in future, could replace mammograms. Investing in these innovations can position the stakeholders at the forefront of the rapidly evolving breast cancer diagnostic devices market.

More Information
Deliverable Type Technology Research
Author Isai Pratha Karthik
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Breast cancer diagnostics
Keyword 2 AI in healthcare
Keyword 3 medical imaging innovations
Podcast No
Predecessor D8E2-01-00-00-00
WIP Number DB17-01-00-00-00

Technology Innovations and Growth Opportunities in Breast Cancer Diagnosis

HealthcareTechnology Innovations and Growth Opportunities in Breast Cancer Diagnosis

Advancing Breast Cancer Diagnosis by Leveraging Acoustic and Nonionizing Radiation Technologies

RELEASE DATE
03-Dec-2024
REGION
North America
Deliverable Type
Technology Research
Research Code: DB17-01-00-00-00
SKU: HC_2024_1169
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_1169